Showing 2261-2270 of 20882 results for "".
- Optimizing Timing in Intracranial Pressure Monitoring: Advancing Strategies for Neurosurgical and ICU Practiceshttps://reachmd.com/news/optimizing-timing-in-intracranial-pressure-monitoring-advancing-strategies-for-neurosurgical-and-icu-practices/2475159/Significant differences in timing between neurosurgeons and ICU physicians, as reported in the TIMING-ICP study, affect the management of intracranial hypertension.
- Gut-Brain Insights in Parkinson’s: New Avenues for Comprehensive Carehttps://reachmd.com/news/gut-brain-insights-in-parkinsons-new-avenues-for-comprehensive-care/2475169/Recent insights into gut-brain signaling expose how microbial imbalances, potentiated by environmental chemicals, accelerate non-motor symptom burden in Parkinson’s disease. Despite advances in dopaminergic therapies, neurologists rout
- Immunotherapy Combinations in Oncology: Expanding Boundarieshttps://reachmd.com/news/immunotherapy-combinations-in-oncology-expanding-boundaries/2475158/As immunotherapy is reshaping oncology, oncologists are leveraging combination therapies to push treatment boundaries and enhance patient outcomes. Combining immunotherapy with targeted therapies has been shown to
- GALDA Co-Director Explains Organization's Work and Impacthttps://reachmd.com/news/galda-co-director-explains-organizations-work-and-impact/2475382/The Gay and Lesbian Dermatology Association (GALDA) is an organization of dermatologists and health-care professionals dedicated to unity and networking of the gay community at dermatology meetings. For Pride Month, we spoke with GALDA co-director William L Waller III, MD, FAAD, to learn more abo
- GALDA Co-Director Explains Organization's Work and Impacthttps://reachmd.com/news/GALDA-Co-Director-Explains-Organizations-Work-Impact/2475171/The Gay and Lesbian Dermatology Association (GALDA) is an organization of dermatologists and health-care professionals dedicated to unity and networking of the gay community at dermatology meetings. For Pride Month, we spoke with GALDA co-director William L Waller III, MD, FAAD, to learn more abo
- New IL-13/IL-31R Bispecific Antibody Data Presented at EAACIhttps://reachmd.com/news/New-IL-13-IL-31R-Bispecific-Antibody-Data-Presented-EAACI/2475170/A new IL-13/IL-31R bispecific antibody demonstrated ability to simultaneously suppress the inflammatory and pruritogenic pathways in atopic dermatitis (AD), according to preclinical study data presented at the European Academy of Allergy and Clinical Immunology (EAACI) Congress 2025 in Glasgow, S
- Harnessing Llama Antibodies and VR for Infection Preventionhttps://reachmd.com/news/harnessing-llama-antibodies-and-vr-for-infection-prevention/2475128/Harnessing llama-derived antibodies and immersive virtual reality training marks a new frontier in preventing and containing infections that evade traditional controls. Healthcare-associated infections continue to challenge clinicians,
- Emerging Synergies in Combating Antimicrobial Resistance: Education Meets Innovationhttps://reachmd.com/news/emerging-synergies-in-combating-antimicrobial-resistance-education-meets-innovation/2475129/Antimicrobial resistance is eroding the effectiveness of cornerstone therapies and accelerating the emergence of drug-resistant pathogens, demanding simultaneous amplification of public understanding and rapid incorporation of novel treatment
- Oculomics: A Non-Invasive Window into Systemic Diseaseshttps://reachmd.com/news/oculomics-a-non-invasive-window-into-systemic-diseases/2475136/As clinicians face the challenge of detecting systemic diseases before irreversible damage occurs, oculomics is emerging as a non-invasive window into cardiovascular, neurodegenerative, and oncologic pathology. Recent studies have expl
- Evolving Euthanasia Laws and Their Impact on Clinical Practicehttps://reachmd.com/news/evolving-euthanasia-laws-and-their-impact-on-clinical-practice/2475143/The inherent tension between evolving euthanasia laws and end-of-life care creates significant variability in physician practice and patient options, yet the influence of legal frameworks on assisted dying remains underrecognized in clinical